STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer.
Liu C, Shi J, Li Q, Li Z, Lou C, Zhao Q, Zhu Y, Zhan F, Lian J, Wang B, Guan X, Fang L, Li Z, Wang Y, Zhou B, Yao Y, Zhang Y.
Liu C, et al. Among authors: guan x.
Clin Sci (Lond). 2019 Mar 1;133(5):645-663. doi: 10.1042/CS20180816. Print 2019 Mar 15.
Clin Sci (Lond). 2019.
PMID: 30782607
Free PMC article.